895 - The Executive Order on Prescription Drug Pricing

About this episode:

This week, President Trump signed an Executive Order aimed at lowering prescription drug costs. In this episode: a look at why the U.S. spends three to four times more for drugs than many peer countries, its current approach to drug pricing policy, the directives laid out in the Executive Order, and how other countries negotiate their prices. Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Guest:

Dr. Gerard Anderson is an expert in health policy and a professor in Health Policy and Management and International Health at the Johns Hopkins Bloomberg School of Public Health.

Host:

Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health.

Show links and related content:

• Delivering Most-Favored Nation Prescription Drug Pricing to American Patients—Executive Order, The White House

• The Potential Impacts of Cuts to Medicaid—Public Health On Call (March 2025)

• .css-j9qmi7{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;font-weight:700;margin-bottom:1rem;margin-top:2.8rem;width:100%;-webkit-box-pack:start;-ms-flex-pack:start;-webkit-justify-content:start;justify-content:start;padding-left:5rem;}@media only screen and (max-width: 599px){.css-j9qmi7{padding-left:0;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;}}.css-j9qmi7 svg{fill:#27292D;}.css-j9qmi7 .eagfbvw0{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;color:#27292D;}